References
- Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020;41:12-85. doi: 10.1093/eurheartj/ehz859.10.1093/eurheartj/ehz85931820000
- Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87-165. doi: 10.1093/eurheartj/ehy394.10.1093/eurheartj/ehy39430165437
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol. 2018;72:2231-2264. doi: 10.1016/j.jacc.2018.08.1038.10.1016/j.jacc.2018.08.103830153967
- Balci B. Tombstoning ST-Elevation Myocardial Infarction. Curr Cardiol Rev. 2009;5:273-278. doi:10.2174/157340309789317869.10.2174/157340309789317869284295921037844
- Wong DT, Leung MC, Das R, et al. Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study. Catheter Cardiovasc Interv. 2012;80:746-53. doi: 10.1002/ccd.23455.10.1002/ccd.2345522422674
- Opincariu D, Chițu M, Rat N, Benedek I. Integrated ST segment elevation scores and in-hospital mortality in STEMI patients undergoing primary PCI. Journal of Cardiovascular Emergencies. 2016;2:114-121. doi: 10.1515/jce-2016-0018.10.1515/jce-2016-0018
- Ahmed N, Carberry J, Teng V, Carrick D, Berry C. Risk assessment in patients with an acute ST-elevation myocardial infarction. J Comp Eff Res. 2016;5:581-593. doi: 10.2217/cer-2016-0017.10.2217/cer-2016-0017598550027580675
- Oh PC, Eom YS, Moon J, et al. Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction. BMC Cardiovasc Disord. 2020;20:486. doi: 10.1186/s12872-020-01777-7.10.1186/s12872-020-01777-7767298033208092
- Ortolani P, Marzocchi A, Marrozzini C, et al. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. Eur Heart J. 2008;29:1241-1249. doi: 10.1093/eurheartj/ehm338.10.1093/eurheartj/ehm33817766280
- Cağli KE, Topaloğlu S, Aras D, et al. Akut miyokard infarktüsü nedeniyle primer perkütan girişim uygulanan hastalarda başvuru anindaki hs-CRP düzeyinin önemi [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction]. Turk Kardiyol Dern Ars. 2009;37:19-25.
- Al Aseri ZA, Habib SS, Marzouk A. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction. Vasc Health Risk Manag. 2019;15:221-227. doi: 10.2147/VHRM.S198452.10.2147/VHRM.S198452664325831410012
- Zhao X, Liu C, Zhou P, et al. Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study. Front Cardiovasc Med. 2020;7:603621. doi: 10.3389/fcvm.2020.603621.10.3389/fcvm.2020.603621772866933330667
- Fanola CL, Morrow DA, Cannon CP, et al. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial. J Am Heart Assoc. 2017;6:e005637. doi: 10.1161/JAHA.117.005637.10.1161/JAHA.117.005637572182529066436
- Ridker PM, MacFadyen JG, Glynn RJ, Bradwin G, Hasan AA, Rifai N. Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial. Eur Heart J. 2020;41:2952-2961. doi: 10.1093/eurheartj/ehaa160.10.1093/eurheartj/ehaa160745383332221587
- Salerno M, Sharif B, Arheden H, et al. Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications. Circ Cardiovasc Imaging. 2017;10:e003951. doi:10.1161/CIRCIMAGING.116.003951.10.1161/CIRCIMAGING.116.003951577785928611116
- Larose E, Rodés-Cabau J, Pibarot P, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol. 2010;55:2459-2469. doi: 10.1016/j.jacc.2010.02.033.10.1016/j.jacc.2010.02.03320510213
- Eitel I, Stiermaier T, Lange T, et al. Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Prediction of Cardiovascular Events Following Myocardial Infarction. JACC Cardiovasc Imaging. 2018;11:1433-1444. doi: 10.1016/j.jcmg.2017.11.034.10.1016/j.jcmg.2017.11.03429454776
- Morariu M, Márton E, Mester A, Rațiu M, Benedek I. Association Between Acute Inflammatory Response and Infarct Size in Stemi Patients Undergoing Primary PCI. Journal Of Cardiovascular Emergencies. 2018;4:140-146. doi: 10.2478/jce-2018-0017.10.2478/jce-2018-0017
- Świątkiewicz I, Magielski P, Kubica J, Zadourian A, DeMaria AN, Taub PR. Enhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure. Int J Mol Sci. 2020;21:807. doi: 10.3390/ijms21030807.10.3390/ijms21030807703752131991903
- Chen RZ, Liu C, Zhou P, et al. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:359-366. Chinese. doi: 10.3760/cma.j.cn112148-20190829-00527.
- Kim D, Choi DH, Kim BB, Choi SW, Park KH, Song H. Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes. J Clin Lab Anal. 2016;30:930-940. doi: 10.1002/jcla.21959.10.1002/jcla.21959680700527075615
- Stone GW, Selker HP, Thiele H, et al. Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. J Am Coll Cardiol. 2016;67:1674-1683. doi: 10.1016/j.jacc.2016.01.069.10.1016/j.jacc.2016.01.06927056772
- Reindl M, Eitel I, Reinstadler SJ. Role of Cardiac Magnetic Resonance to Improve Risk Prediction Following Acute ST-Elevation Myocardial Infarction. J Clin Med. 2020;9:1041. doi: 10.3390/jcm9041041.10.3390/jcm9041041723109532272692
- Reinstadler SJ, Thiele H, Eitel I. Risk stratification by cardiac magnetic resonance imaging after ST-elevation myocardial infarction. Curr Opin Cardiol. 2015;30:681-689. doi: 10.1097/HCO.0000000000000227.10.1097/HCO.000000000000022726398412
- Gupta S, Gupta MM. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J. 2016;68:539-551. doi: 10.1016/j. ihj.2016.04.006.